secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIGAND PHARMACEUTICALS INC (LGND)
CIK:        0000886163
Form:       8-K
Filed at:   2025-08-11T23:59:59+00:00
Accession:  0001193125-25-177452
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ligand proposes $400M convertible notes due 2030; up to $60M greenshoe
----------------------------------------------------------------------

- Offering $400M aggregate principal amount of convertible senior notes due Oct 1, 2030 to QIBs.
- Initial purchasers have 13-day option to buy up to an additional $60M of notes.
- Up to $30M of net proceeds used to repurchase common stock from note purchasers.
- Remaining net proceeds for general corporate purposes, including potential acquisitions.
- Convertible note hedge and warrant transactions entered to manage dilution and offset cash payments.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/886163/000119312525177452/0001193125-25-177452-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/886163/000119312525177452/d434030d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-177452

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer